humanitarian
Human medicines European public assessment report (EPAR): Riltrava Aerosphere, formoterol fumarate dihydrate,glycopyrronium,budesonide, Date of authorisation: 06/01/2022, Revision…
Human medicines European public assessment report (EPAR): Pemetrexed Baxter, pemetrexed, Date of authorisation: 09/12/2022, Status: Withdrawn
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Riltrava Aerosphere, formoterol fumarate dihydrate,glycopyrronium,budesonide, Date of authorisation: 06/01/2022, Revision…EMA What Is NewHuman medicines European public assessment report (EPAR): Riltrava Aerosphere, formoterol fumarate dihydrate,glycopyrronium,budesonide, Date of authorisation: 06/01/2022, Revision…EMA What Is NewHuman medicines European public assessment report (EPAR): Leqvio, inclisiran, Date of authorisation: 09/12/2020, Revision: 12, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Leqvio, inclisiran, Date of authorisation: 09/12/2020, Revision: 12, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 8, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 8, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Byetta, exenatide, Date of authorisation: 20/11/2006, Revision: 30, Status: WithdrawnEMA What Is NewHuman medicines European public assessment report (EPAR): Byetta, exenatide, Date of authorisation: 20/11/2006, Revision: 30, Status: WithdrawnEMA What Is NewHuman medicines European public assessment report (EPAR): Bydureon, exenatide, Date of authorisation: 17/06/2011, Revision: 27, Status: WithdrawnEMA What Is NewHuman medicines European public assessment report (EPAR): Bydureon, exenatide, Date of authorisation: 17/06/2011, Revision: 27, Status: WithdrawnEMA What Is NewHuman medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation: 01/08/2024, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation: 01/08/2024, Revision: 2, Status: Authorised4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources